Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Upgrades

Upgrades

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Upgrades

JP Morgan Upgrades Hubbell to Neutral, Announces $205 Price Target

By Benzinga Newsdesk
Today, 7:20 AM
JP Morgan analyst Stephen Tusa upgrades Hubbell (NYSE:HUBB) from Underweight to Neutral and announces $205 price target.

HUBB

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Upgrades

Needham Upgrades NeoGenomics to Buy, Announces $15 Price Target

By Benzinga Newsdesk
Today, 6:37 AM
Needham analyst Mike Matson upgrades NeoGenomics (NASDAQ:NEO) from Hold to Buy and announces $15 price target.

NEO

Read More
1 minute read
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Upgrades

FibroGen Shares Gain As Analyst Creates Bullish Pitch On Pulmonary Fibrosis Opportunity

By Vandana Singh
Yesterday, 2:26 PM
William Blair has upgraded FibroGen Inc (NASDAQ:FGEN) from Market Perform To Outperform, citing a deep dive opportunity for its wholly owned monoclonal…

FGEN

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Upgrades

Raymond James Upgrades Silvercorp Metals to Outperform, Raises Price Target to C$6.15

By Benzinga Newsdesk
Yesterday, 9:14 AM
Raymond James upgrades Silvercorp Metals (TSX:SVM) from Market Perform to Outperform and raises the price target from C$5 to C$6.15.

TSX:SVM

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Upgrades

B of A Securities Upgrades Fleetcor Technologies to Buy, Raises Price Target to $240

By Benzinga Newsdesk
Yesterday, 7:38 AM
B of A Securities analyst Mihir Bhatia upgrades Fleetcor Technologies (NYSE:FLT) from Neutral to Buy and raises the price target from $208 to $240.

FLT

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Upgrades

Atlantic Equities Upgrades LyondellBasell Industries to Overweight, Announces $110 Price Target

By Benzinga Newsdesk
Yesterday, 7:35 AM
Atlantic Equities analyst Colin Isaac upgrades LyondellBasell Industries (NYSE:LYB) from Neutral to Overweight and announces $110 price target.

LYB

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Upgrades

Goldman Sachs Upgrades Inter & Co to Buy, Lowers Price Target to $4.2

By Benzinga Newsdesk
Yesterday, 5:40 AM
Goldman Sachs analyst Tito Labarta upgrades Inter & Co (NASDAQ:INTR) from Neutral to Buy and lowers the price target from $4.6 to $4.2.

INTR

Read More
1 minute read
  • Analyst Ratings
  • News
  • Upgrades

William Blair Upgrades FibroGen to Outperform

By Benzinga Newsdesk
Yesterday, 5:32 AM
William Blair analyst Andy Hsieh upgrades FibroGen (NASDAQ:FGEN) from Market Perform to Outperform.

FGEN

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Earnings
  • General
  • News
  • Price Target
  • Upgrades

Morgan Stanley Upgrades Colgate-Palmolive On Attractive Growth Opportunity

By Shivani Kumaresan
January 30, 2:08 PM
Morgan Stanley analyst Dara Mohsenian upgraded Colgate-Palmolive Company (NYSE:CL) from Equal-Weight to Overweight with a price target of $82. The analyst believes…

CL

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Commodities
  • Downgrades
  • Markets
  • News
  • Penny Stocks
  • Top Stories
  • Upgrades

South African Gold Mining Stock AngloGold Ashanti Gets Upgraded, Gold Fields Downgraded

By Wayne Duggan
January 30, 1:37 PM
The SPDR Gold Trust (NYSE: GLD) is up 15.8% since Oct. 1, and gold prices are approaching $2,000 per ounce for the first time since April 2022.

AU

Posts navigation

1 2 … 401 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service